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ABSTRACT
Being a transcription factor, NF-jB regulates gene expressions involving cell survival and prolifer-
ation, drug resistance, metastasis, and angiogenesis. The activation of NF-jB plays a central role in
the development of inflammation and cancer. Thus, the down-regulation of NF-jB may be an
exciting target in prevention and treatment of cancer. NF-jB could act as a tumor activator or
tumor suppressant decided by the site of action (organ). Polyphenols are widely distributed in
plant species, consumption of which have been documented to negatively regulate the NF-jB sig-
naling pathway. They depress the phosphorylation of kinases, inhibit NF-jB translocate into the
nucleus as well as interfere interactions between NF-jB and DNA. Through inhibition of NF-jB,
polyphenols downregulate inflammatory cascade, induce apoptosis and decrease cell proliferation







Cancer, also known as neoplasm or malignant tumor, is a
multifactorial disease caused by alteration of gene expression
and cell signaling pathways (Rajagopal et al. 2018b). It is
characterized by abnormal and endless cell divisions, which
form growths called tumors, invade nearby tissues, spread to
distant organs and can be life threatening (https://www.can-
cer.gov/about-cancer/understanding/what-is-cancer). In
2018, cancer is accountable to 9.6 million deaths with an
incidence of 1 in 6 deaths all around the world (WHO 2018,
12 September). In addition to environmental factors and cell
mutations, recent studies have shown that the epigenetic
changes such as DNA methylation may cause cellular trans-
formation, which eventually lead to cancer (Rajagopal et al.
2018b). In particular, the involvement of NF-jB (nuclear
factor-jB) pathway in inflammation processes and cancer
development, have been widely reported (DiDonato,
Mercurio, and Karin 2012; De Simone et al. 2015; Zhang
et al. 2015, 2018). The clinical evidences illustrated that
NF-jB pathway components are essential players in the
cancer onset and progression, which regulate gene expres-
sions related to cell survival and proliferation, drug resist-
ance, metastasis, and angiogenesis (Zhang, Lenardo, and
Baltimore 2017).
In light of these assumptions, NF-jB is a molecular target
in cancer. In this perspective, several phytochemicals were
identified and revealed to have significant targeting and
inhibitory effects on NF-jB signaling (Sethi and Tergaonkar
2009; Gupta et al. 2011; Shanmugam et al. 2016). Among
these polyphenols, resveratrol (Ryu et al. 2011; Tsai et al.
2012; Aravindan et al. 2013; Ren et al. 2013; Jiao et al. 2015;
Zhang et al. 2015), curcumin (Gupta, Kismali, and Aggarwal
2013; Marquardt et al. 2015; Puliyappadamba et al. 2015;
Basha et al. 2016; Bisht et al. 2016; De Porras et al. 2016;
Kunnumakkara et al. 2017), epigallocatechin gallate (Qin
et al. 2012; Zhang et al. 2012; Zhou et al. 2012, 2014; Chung
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and Vadgama 2015; Li et al. 2015), genistein (Pan et al.
2012; Yamasaki et al. 2013; Du et al. 2016), and cardamonin
(James et al. 2017) are the most studied for their capabilities
to inhibit cancer cell proliferation by blocking the nuclear
translocation of NF-jB or reducing NF-jB activation
(Rajagopal et al. 2018a this paper cannot be found in
the references).
The objective of the manuscript is to review research pro-
gress on the significant roles of polyphenols in modulating
NF-jB and anticancer effects. Additionally, the chemistry,
food sources and bioavailability of the representative poly-
phenols are also reported. Electronic databases including
PubMed, WOS and Scopus were searched using the topics
(“NF-jB polyphenols” OR “NF-jB flavonoids” OR “NF-jB
phenolic acids” OR “NF-jB stilbenoids” OR “NF-jB
anthocyanins”). Datasets were outlined from 2000 to 2018.
NF-jB: what, when, where?
NF-jB is a group of dimeric transcription factors, whose
family in mammal contains five genes, namely NF-jB1
(p50/p105), NF-jB2 (p52/p100), RelA (p65), RelB and c-Rel
(Karin and Ben-Neriah 2000; Barroso et al. 2016). Their
proteins are characterized by a 300-amino acid conserved
Rel Homology Domain (RHD) locating toward the N ter-
minus, which is involved in the dimerization process, inter-
action with their specific inhibitors, and DNA binding
(Hayden and Ghosh 2004). Without stimulation, NF-jB
dimers bind to IjB and keep in an inactive state. Once
stimulated, NF-jB regulates gene expressions that impact
many life processes, including cell growth, proliferation,
inflammatory, immune responses, and neoplastic
transformations in many tumors (Figure 1) (Rao et al. 2011;
Jana et al. 2017).
As reported, NF-jB can be activated via different
molecular pathways (Figure 2). The first one is known as
the canonical or classical activation pathway, which refers to
dimmers composed of p65, c-Rel, and p50. Pro-inflamma-
tory cytokines and infections trigger this pathway by activat-
ing the b unit of IjB kinase (IKK) complex (IKKb), which
then phosphorylates IjB proteins, degrades IjB and liberates
NF-jB dimmers. Free NF-jB dimmers then translocate to
the nucleus, bind to specific sequences and activate the tran-
scription of 100 genes involved in biological processes
(Hayden and Ghosh 2004). The second pathway called alter-
native activation pathway applies to dimmers consisting of
RelB and p100 subunits. Tumor necrosis factor (TNF) fam-
ily members regulate this pathway by activating the IKKa
catalytic subunit. The activated IKKa phosphorylates p100,
which subsequently undergoes proteolysis and releases p52,
the latter then translocates to the nucleus and activates tran-
scription of specific target genes (Dolcet et al. 2005). It is
suggested that the activated NF-jB is bound to jB sites in
order to modify gene expression and encode various pro-
teins (Hayden and Ghosh 2011).
The NF-jB signaling pathway can also be activated by
oxidative stress and stimuli like IL-1 and TNF-a (Chen et al.
2011). Studies reported the involvement of NF-jB mediated
upregulation of HIF-1 (hypoxia-inducible factor-1) in oxida-
tive stress. Elevated level of ROS (reactive oxygen species)
can trigger NF-jB, which results in increasing HIF-1a and
plays a vital role in the pathogenesis of cardiovascular disor-
ders and tumor progression (Bonello et al. 2007). In tumors,
NF-jB and HIF-1a are regularly activated and concerned
Figure 1. NF-jB transcriptionally regulates hundreds of genes, when getting stimulated by numerous stimuli.
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with tumor development, progression and resistance to
chemotherapy (Tafani et al. 2013). The upregulation of NF-
jB in diabetes and its complications has been documented.
According to available literature, hyperglycemia increases
NF-jB gene expression and causes insulin resistance in adi-
pose tissues as a pro-inflammatory agent (Khosravi et al.
2018). Viruses target components of the NF-jB signaling
pathway to facilitate cell survival and replication. Frequent
activation of NF-jB in chronic viral infections may lead to
carcinogenesis (Hiscott, Kwon, and Genin 2001).
NF-jB transcription factor works as an endogenous
tumor promoter, as it plays a central role in carcinogenesis
of several types of B-cell tumors, such as multiple myeloma
(MM) (Allavena et al. 2008; Demchenko and Kuehl 2010).
NF-jB gives a critical connection between cancer and
inflammation. Inflammatory environment, especially in
malignant progression, can lead to NF-jB activation in can-
cers. Moreover, NF-jB enhances the expression of TNF-a,
IL-6, and Bcl-XL. IL-6 and TNF-a are famous tumor pro-
moting cytokines, whereas Bcl-XL is a survival gene (Karin
2009). Receptor activator of NF-jB (RANK), RANKL (a lig-
and of RANK) and osteoprotegerin (OPG, a decoy receptor
of RANKL) regulate osteoclasts formation and activity,
which leads to bone remodeling. It has been suggested that
the RANK/RANKL/OPG pathway can predict bone diseases,
including bone metastasis recurrence and prognosis (Santini
et al. 2011). To prevent carcinogenesis, the NF-jB signaling
pathway could be considered as a target. However, before
initiating NF-jB inhibition approaches for cancer preven-
tion, the role of NF-jB in the cancer pathogenesis should be
carefully evaluated because in different organs NF-jB may
either promote (colon and liver) or suppress (skin and liver)
tumor formation (Lin et al. 2010).
NF-jB and inflammation
Inflammation is a tissue process consisting of a series of
molecular, cellular and vascular phenomena with defensive
purpose against physical, chemical or biological aggressions
(Kumar et al. 2015). It is an immediate and nonspecific
response, although it may facilitate the development of a
specific response. As a consequence of the inflammation,
vasodilatation and enhanced permeability occur near the
inflammatory focus in order to facilitate the arrival and
translocation of leukocytes, as well as other inflammatory
mediators (Geering et al. 2013; Kumar et al. 2015). The
ultimate goal of inflammation is to eliminate or inhibit
infections or cell damage, help the body recovering to nor-
mal conditions and restore the function of affected tissues
or organs (Medzhitov 2008). However, inflammation that
should be an acute and self-limiting process can become
chronic due to a non-resolution or incorrect resolution of
the acute inflammatory response. One of the most common
reasons for this type of inflammation is usually associated
with metabolic diseases such as metabolic syndromes and
cancers (Minihane et al. 2015). In this sense, chronic and
persistent inflammation substantially increases the risk of
malignant transformation of cells (Kundu and Surh 2008;
Hoesel and Schmid 2013). Within the inflammatory process,
long-standing activation of NF-jB is linked with pro-
Figure 2. Molecular pathways of NF-jB activation. The conical pathway is triggered by proinflammatory cytokines, a variety of cellular stresses, microbial or viral
infections by activating IKK complex. IKK phosphorylates IkB in serine residues leading to the degradation of IjB and liberation of NF-jB dimmers, with the latter
subsequently translocating to the nucleus. The alternative pathway is mediated by TNF receptor family and viral proteins such as LMP-1 from Epstein Barr virus
(EBV), which activate the IKKa subunit. IKKa phosphorylates p100 which is then proteolysed to produce the p52 mature form. The dimmers then translocated to the
nucleus to induce the transcription of specific target genes. Interleukin 1 beta (IL-1b); Tumor necrosis factor alpha (TNF-a); Cluster of differentiation 40 (CD40);
Lymphotoxin beta (LTb); B-cell activating factor (BAF).
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tumorigenic results. It has been suggested that subjects suf-
fering from chronic inflammatory diseases, including
chronic hepatitis and pancreatitis, gastric inflammation
induced by Helicobacter pylori, and inflammatory bowel dis-
eases, present increasing risk of some cancers (Grivennikov
2013; Hausmann et al. 2014; Wang et al. 2014).
The NF-jB pathway is essential in modulation of the
inflammatory processes since its activation leads to
enhanced expression of pro-inflammatory cytokines, chemo-
attractant proteins, and their specific receptors.
Furthermore, NF-jB transcription cascade can also be acti-
vated by increased levels of pro-inflammatory cytokines
(Perkins 2004). During chronic inflammation, immune cells
generate reactive nitrogen species (RNS) and reactive oxygen
species (ROS), which can mediate the carcinogenic process.
Excessive production of RNS and ROS in the inflamed tissue
can lead to tumorigenesis by inducing DNA damage and
mutations, which correspondingly result in the activation
and/or inactivation of oncogenes and tumor suppressor
genes, respectively (Grivennikov, Greten, and Karin 2010).
Besides, excess of ROS produced by immune cells also rein-
forces the inflammatory responses mediated by NF-jB in
the microenvironment of the tumor.
Another factor responsible to carcinogenesis is the pos-
sible appearance of mutations in the NF-jB genes
(Figure 3). Although mutations in the NF-jB encoding
genes related with inflammatory pathway have been reported
in B-cells lymphoid tumors, their presence in the solid
tumor is not familiar (Sun et al. 2014). The existence in
solid malignancies of mutations in genes upstream of the
NF-jB signaling pathway include Ras, EGFR, PDGF or
human epidermal growth factor receptor-2 (HER2), which
can direct the constitutive activation of NF-jB (Chaturvedi
et al. 2011). NF-jB can also induce transcription of genes
related with cell proliferation like C-MYC and cyclin D1
(Guttridge et al. 1999; Yuan et al. 2016), with angiogenesis
and metastasis like adhesion molecules, VEGF, matrix met-
alloproteinases, and with anti-apoptosis like Bcl-2 and Bcl-X
(Xie et al. 2010; Acharyya et al. 2012).
NF-jB and polyphenols
Being a regulator of 100 target genes, NF-jB could be a
molecular target to treat diseases, including but not limited
to inflammatory disorders, such as asthma, arthritis and
auto-immune diseases. Newly, many plant-derived com-
pounds have been identified as potential modulators of the
NF-jB signaling pathway (Miao et al. 2019; Zhao et al.
2019). Natural polyphenols are considered as the most
important bioactive natural products (Devi et al. 2015; Curti
et al. 2017; Chen et al. 2018) as well as most widely distrib-
uted dietary phytochemicals, which exhibit various pharma-
cological and physiological functions (Xiao and H€ogger
2015; Xiao et al. 2016; Xiao 2017; Khan et al. 2018, 2019).
In this review, we shall focus on the medicinal chemistry of
polyphenols regarding their NF-jB inhibition capacity
(Table 1). Bellik et al. (2012) reviewed the anti-inflammatory
activities of phytochemicals, their target pathways, mecha-
nisms and clinical efficiency. The anti-inflammatory effects
of polyphenols are generally attributed to the suppression of
canonical NF-jB pathway, which degraded IKK complex to
release NF-jB.
In the respect of targeting the NF-jB pathway, some pol-
yphenols are reported to inhibit the phosphorylation of kin-
ases, which prevent NF-jB translocation and thus inhibit
Figure 3. The relation between NF-jB activation and cancer. Mutations in NF-jB, but mostly in upstream activators can lead to excessive activation of NF-jB and
the induction of genes related to chronic inflammation, cell proliferation, metastasis, and angiogenesis. Cyclooxygenase-2 (COX-2); Epidermal growth factor receptor
(EGFR); Human epidermal growth factor receptor-2 (HER2); Platelet-derived growth factor (PDGF); Tumor necrosis factor alpha (TNF-a); Vascular endothelial growth
factor (VEFG).
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the transcription of pro-inflammatory mediators. In add-
ition, polyphenols also inhibit interactions between NF-jB
and its targeted DNA (Ruiz and Haller 2006). Both mecha-
nisms can finally inhibit the expression of several pro-
inflammatory proteins and enzymes regulated by NF-jB.
Phenolic acids
Delay in the onset of inflammatory diseases with consump-
tion of hydroxycinnamic acid derivatives is reported through
antioxidant (AOX) and antiradical properties, by acting on
pathways of activation of enzymes and expression of genes.
The ester of caffeic acid, chlorogenic acid, with quinic acid,
having distinct pharmacological profile has been described
to exert potent anti-inflammatory, immunoprotective, anti-
oxidant and anti-bacterial properties.
Recently, Ye et al. (2017) explored the mechanism of
chlorogenic acid in acute kidney injury and demonstrated
that chlorogenic acid dose-dependently suppresses LPS-
induced creatinine and pro-inflammatory cytokines includ-
ing IL-6, and IL-1b and TNF-a in serum and tissue. As
reported from in vivo studies, chlorogenic acid suppressed
serum BUN and creatinine levels and LPS-induced IL-6, IL-
1b and TNF-a production in both kidney tissues and serum.
It also attenuated LPS-induced kidney histopathologic
changes. Chlorogenic acid as a significant component in
Cymbopogon citratus was described to decrease in NF-jB-
dependent NO production in murine macrophages
(Francisco et al. 2013). Oleuropein and hydroxyl tyrosol
interfere with tau protein and amyloid Ab aggregation
which results in neuroprotection. St-Laurent-Thibault et al.
(2011) linked reduction in Ab-induced toxicity by these
compounds in cultured neuroblastoma cells with modulation
of NF-jB signaling.
Curcumin
The extensive literature on the health benefit of curcumin,
including many clinical studies, has been recently reviewed
by Hewlings and Kalman (2017). Curcumin suppresses IL-1,
-2, -6, -8, -12 and TNF-a and decreases the expression levels
of iNOS, LPO and COX-2 (Abe, Hashimoto, and Horie
1999). It has also been indicated to inhibit the NF-jB path-
way in nonalcoholic fatty liver disease (Jimenez-Flores
et al. 2014).
Curcumin was reported to block the translocation of p65
subunits to nucleus by suppression of phosphorylation and
degradation of IjBa, which thus intervened the NF-jB sig-
naling pathway. Curcumin was also shown to inhibit IKK
activation (Shakibaei et al. 2007). Despite having potent
antioxidant and anti-inflammatory properties, curcumin is
not much effective against systemic diseases because of its
poor bioavailability. Curcumin has not been successful in
any clinical trials, and several papers involving it with cancer
treatment have been retracted (Prasad et al. 2017).
Stilbenoids
Resveratrol interferes with NF-jB signaling in diverse differ-
ent cell types, such as H4 cells, Jurkat, U-937 and HeLa
(Manna, Mukhopadhyay, and Aggarwal 2000). Several stud-
ies illustrated that resveratrol suppressed NF-jB activation
in U-937 cells after stimulation with PMA (Aggarwal and
Shishodia 2006), okadaic acid, H2O2, TNF-a, ceramide or
LPS (Harikrishnan et al. 2018). Resveratrol modulates the
NF-jB signaling pathway in an unspecific manner. It also
inhibits the activation of c-Jun kinase and MAPK kinase
induced by TNF-a in U-937 cells. Some specificity was
found as it inhibits the translocation of the p65 NF-jB sub-
unit into the nucleus. Several studies showed that resveratrol
suppressed the production and expression of IL-6, nitric
oxide in LPS-stimulated RAW264.7 cells. Furthermore,
resveratrol also suppresses the phosphorylation of IjB-a
(Kumar and Sharma 2010; Ma et al. 2015).
Flavonoids
Devi, Kiruthiga, and Pandian (2009) described the inhibitory
capability of flavonoids against NF-jB signaling pathway
and reviewed the effects of various flavonols (such as quer-
cetin and kaempferol) and flavones (like flavone, chrysin,
and baicalin) on ICAM-1 expression, which is stimulated by
TNF-a. Amongst the given flavonoids, apigenin, kaempferol,
luteolin, and chrysin are negative regulators for ICAM-1
expression. Besides this, other experiments recommended
that various activities like IjB kinase activity, NF-jB DNA-
Table 1. Classification of phenolic compounds according to structure.
Phytochemicals Classification Skeleton Basic structure
Gallic acid Phenolic acids C6-C1 COOH
Gallacetophenone Acetophenones C6-C2 O OCH3
p-Hydroxyphenyl-acetic
acid
Phenylacetic acid C6-C2 COOH
p-Coumaric acid Hydroxycinnamic acids C6-C3 COOH
Esculetin Coumarins C6-C3 O O
Juglone Naphthoquinones C6-C4 O
O
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protein binding activity, IjB degradation, and NF-jB luci-
ferase activity were actively inhibited by luteolin and apige-
nin (Hashimoto et al. 2017).
Hispidulin inhibits the activation of p38 and JNK
induced by RANKL (Nepal et al. 2013). Kaempferol sup-
presses the phosphorylation of IRS-1, IKKa, and IKKb with
a decreased NF-jB level and thus lowers IL-6 and TNF-a
levels in diabetic mice (Luo et al. 2015). Quercetin has been
indicated to downregulate the expression of NF-jB in non-
alcoholic fatty liver disease (Porras et al. 2017). Amrutha
et al. (2014) explored the structure-activity relationships of
flavonoids on inhibiting NF-jB signaling in MDA-MB-231
cells. It was found that the multi-methyl flavonoids such as
chrysoeriol, diosmetin, and acacetin showed higher inhib-
ition ability than non-methyl flavonoids (Amrutha
et al. 2014).
Anthocyanins
Enhancement of cognitive and motor function during aging
has also been documented with the use of anthocyanins
from berries due to their antioxidant and neuroprotective
properties (Poulose, Carey, and Shukitt-Hale 2012). Down-
regulation of pro-inflammatory cytokines by anthocyanins
(100mg/kg) in multiple sclerosis rats could protect against
oxidative stress caused by demyelination (Carvalho et al.
2015). The modulation of Nrf2 and NF-jB signaling path-
ways by anthocyanins are also linked with their neuropro-
tective effects against oxidative and inflammatory damages
(de Pascual-Teresa 2014). A blueberry anthocyanin
decreased the expression of iNOS, COX2 and NO (Lau
et al. 2009).
Catechins
Catechin suppressed NF-jB signaling pathway in allergic
rhinitis mice by reducing p-NF-jBp65 and NF-jBp65 levels,
suppressing the degradation of IjB-a, and inhibiting nuclear
translocation of NF-jBp65 (Pan et al. 2018). Catechin 7-O-
b-D-glucopyranoside could inhibit intestinal inflammation
in colitic rats by prevention of the phosphorylation of p38
MAPK, IjB-a, and DNA-NF-jB binding (Kook et al. 2015).
EGCG downregulated the expression of COX-2 via restrain-
ing NF-jB signaling pathway in colon cancer cells (Peng
et al. 2006). EGCG can also suppress the expressions of P38
and nuclear NF-jB in human RASFs, whereas EC and EGC
did not show any inhibition effects (Fechtner et al. 2017).
Ellagitannins
A class of polyphenols, i.e. ellagitannins and ellagic acid
conjugates are mostly found in pomegranates, raspberries,
strawberries, blackberries, nuts, and grapes. Anti-inflamma-
tory activities of pomegranate ellagitannins at the gastro-
intestinal level has been reported from various studies
(Colombo, Sangiovanni, and Dell’Agli 2013). The ellagitan-
nins from raspberries and blackberries suppress NF-jB tran-
scription and nuclear translocation. It also diminished the
secretion of IL-8 at minute concentrations, which was
induced by IL-1b and TNF-a (Sangiovanni et al. 2013).
Agrimoniin, a dimeric ellagitannin from the Rosaceae family,
is one of the main phenolic compounds found in strawber-
ries and other plants. Agrimoniin inhibited IL-8 secretion
mostly due to negative regulation of NF-jB signaling path-
way (Grochowski et al. 2017).
Polyphenols targeting NF-jB in cancers
Polyphenols inhibit inflammatory processes, induce apop-
tosis and decrease cell proliferation and metastasis through
targeting NF-jB signaling pathway (Figure 4).
Effect on inflammation
As documented in various studies, several polyphenols exert
anti-inflammatory effects by negative regulation of NF-jB,
which contribute to their chemopreventive and chemopro-
tective activities (Surh et al. 2001). Curcumin downregulates
the expression of inflammation and cancer-related genes,
including TNF-a, IL-1b, and NF-jB (Duvoix et al. 2005).
Curcumin-mediated suppression of NF-jB result in blocking
the pro-metastatic positive feedback loop. Metastases in
breast and prostate cancer animals was obviously repressed
by curcumin (Pfeffer et al. 2015). While investigating the
anti-inflammatory activities of capsaicin in LPS-stimulated
macrophages, Park et al. concluded from an experimental
study in 2004 that consumption of capsaicin inhibited the
production of pro-inflammatory cytokines by inactivation of
NF-jB (Park et al. 2004).
An extract rich in procyanindins inhibits the expression
of iNOS and the translocation of NF-jB, and thus modu-
lates inflammatory response in activated macrophages (Terra
et al. 2007). Along with NF-jB, another transcription factor
HIF1-a plays a key role in controlling vital cellular processes
including inflammatory reparative response. Resveratrol and
other members of sirtuins are known for regulation of both
these transcription factors (Tafani et al. 2013). Wheeler et al.
Figure 4. Effects of polyphenols on inflammation, apoptosis and metastasis.
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(2004) concluded that EGCG from green tea could restrain
IL-8-mediated activation of NF-jB signaling pathway and
suppress IL-8 gene expression via inhibiting the phosphoryl-
ation of p65 subunit.
Effect on apoptosis
Chemopreventive agents including polyphenols can inhibit
tumor growth by arresting cell cycle and inducing cell apop-
tosis (Lin 2002). Tea polyphenols possess antiproliferative
and apoptotic effects having anticancer capacities against
various cancer cells. EGCG and theaflavins induce apoptosis
in human cervical cancer cells by suppressing the activation
of NF-jB and Akt via blocking phosphorylation of jBa and
jBb subunits, thus down-regulating COX-2 (Singh et al.
2011). Other molecular mechanisms of apoptosis induction
by tea polyphenols include upregulating the expression levels
of p53, p21, p73, caspase-3, caspase-9, caspase-8, and Bax;
while down-regulating the expression levels of Bcl-2 and
Bcl-xL (Zhao et al. 2014; Wang et al. 2018). Synergistic anti-
cancer effects of bleomycin and tea polyphenols in human
cervical cancer cells via induction of apoptotic pathways
were studied, and it was suggested that both of these agents
might provide an effective combination therapy for cervical
cancer (Alshatwi et al. 2016).
In 2004, Gupta et al. (2004) reported that tea polyphenols
EGCG induced apoptosis and inhibited cell proliferation in
a dose-dependent fashion by negative regulation of trans-
location of NF-jB. Hafeez et al. (2008) demonstrated that
delphinidin induced cell growth arresting and apoptosis by
restraining NF-jB binding to DNA in prostate cancer cells.
Curcumin can induce apoptosis by blocking the NF-jB acti-
vation in cervical cancer cells (Divya and Pillai 2006). The
expression levels of Bcl-2 involved in apoptosis was up-regu-
lated by curcuminoids (Duvoix et al. 2005). Intake of resver-
atrol has been reported to induce apoptosis, inhibit cell
proliferation and decrease chemoresistance via suppressing
STAT3 and NF-jB pathways (Benitez et al. 2007).
Effect on tumor metastasis
Several phenolic compounds such as curcumin, resveratrol,
gallic acid, caffeic acid, carnosol have potential effects on
cancer invasion and metastasis (Weng and Yen 2012).
Proanthocyanidins from grape seeds decrease the expression
of MMP in human prostate carcinoma cells, which is associ-
ated with the inhibition of MAPK activation and NF-jB sig-
naling pathway. MMP has been recognized to facilitate
tumor cell invasion and metastasis of prostate cancer
(Vayalil, Mittal, and Katiyar 2004). In oral cancers, antho-
cyanins have been demonstrated to decrease cell prolifer-
ation, metastasis through negatively regulating NF-jB
pathway, inhibiting MMP expression and down-regulating
MAPK pathway (Fan et al. 2015). In 2004, Chung et al.
(2004) successfully studied the anticancer and anti-meta-
static activities of caffeic acid and its phenethyl ester on hep-
atocarcinoma cells. These two compounds were found to
suppress tumor growth in vitro as well as in vivo by decreas-
ing NF-jB and MMP activities (Chung et al. 2004).
Conclusion
The transcription factor NF-jB exerts an essential function in
regulating gene expression of many biological processes
including cell growth, metabolic reprograming, inflammation,
and cancer. When getting stimulated, it promotes nuclear
translocation and activates the target genes transcription. NF-
jB may be tumor promoting or tumor suppressing depending
upon the site of carcinogenesis. Genetic modification regulat-
ing NF-jB activation may enhance NF-jB activity. It also
links inflammation with cancer. Down-regulating NF-jB sig-
naling pathway could be a molecular target for treating
inflammation, age-related diseases, and cancer prevention.
Polyphenols can negatively regulate NF-jB signaling pathway,
induce apoptosis, decrease cell proliferation and metastasis,
and possess anti-inflammatory effects. Polyphenols prevent
NF-jB translocation into the nucleus through inhibition of
phosphorylation of kinases. They also interfere the binding of
activated NF-jB with target DNA. Considering the central
role in regulating the NF-jB signaling pathway by polyphe-
nols, there is the possibility to develop more specific agents
with higher success rates that can modulate molecular path-
way by acting on different steps.
Funding
A. Sureda was supported by the Programme of Promotion of
Biomedical Research and Health Sciences (CIBEROBN CB12/
03/30038).
ORCID
Antoni Sureda Gomila http://orcid.org/0000-0001-8656-6838
Seyed Mohammad Nabavi http://orcid.org/0000-0001-8859-5675
Maria Daglia http://orcid.org/0000-0002-4870-7713
Ana Sanches Silva http://orcid.org/0000-0002-0226-921X
Jianbo Xiao http://orcid.org/0000-0003-3311-770X
References
Abe, Y., S. Hashimoto, and T. Horie. 1999. Curcumin inhibition of
inflammatory cytokine production by human peripheral blood
monocytes and alveolar macrophages. Pharmacological Research
39 (1):41–7. doi: 10.1006/phrs.1998.0404.
Acharyya, S., T. Oskarsson, S. Vanharanta, S. Malladi, J. Kim, P. G.
Morris, K. Manova-Todorova, M. Leversha, N. Hogg, V. E. Seshan,
et al. 2012. A CXCL1 paracrine network links cancer chemoresistance
and metastasis. Cell 150 (1):165–78. doi: 10.1016/j.cell.2012.04.042.
Aggarwal, B. B., and S. Shishodia. 2006. Molecular targets of dietary
agents for prevention and therapy of cancer. Biochemical
Pharmacology 71 (10):1397–421. doi: 10.1016/j.bcp.2006.02.009.
Allavena, P., C. Garlanda, M. G. Borrello, A. Sica, and A. Mantovani.
2008. Pathways connecting inflammation and cancer. Current
Opinion in Genetics & Development 18 (1):3–10. doi: 10.1016/j.gde.
2008.01.003.
Alshatwi, A. A., V. S. Periasamy, J. Athinarayanan, and R. Elango.
2016. Synergistic anticancer activity of dietary tea polyphenols and
bleomycin hydrochloride in human cervical cancer cell: Caspase-
2796 H. KHAN ET AL.
dependent and independent apoptotic pathways. Chemico-Biological
Interactions 247:1–10. doi: 10.1016/j.cbi.2016.01.012.
Amrutha, K., P. Nanjan, S. K. Shaji, D. Sunilkumar, K. Subhalakshmi,
L. Rajakrishna, and A. Banerji. 2014. Discovery of lesser known fla-
vones as inhibitors of NF-jB signaling in MDA-MB-231 breast can-
cer cells-A SAR study. Bioorganic & Medicinal Chemistry Letters 24
(19):4735–42. doi: 10.1016/j.bmcl.2014.07.093.
Aravindan, S., M. Natarajan, T. S. Herman, V. Awasthi, and N.
Aravindan. 2013. Molecular basis of ‘hypoxic’breast cancer cell radio-
sensitization: Phytochemicals converge on radiation induced Rel sig-
naling. Radiation Oncology 8 (1):46. doi: 10.1186/1748-717X-8-46.
Barroso, M., D. Kao, H. J. Blom, I. T. de Almeida, R. Castro, J.
Loscalzo, and D. E. Handy. 2016. S-adenosylhomocysteine induces
inflammation through NFkB: A possible role for EZH2 in endothe-
lial cell activation. Biochimica et biophysica acta (BBA) - Molecular
Basis of Disease 1862 (1):82–92. doi: 10.1016/j.bbadis.2015.10.019.
Basha, R., S. F. Connelly, U. T. Sankpal, G. P. Nagaraju, H. Patel, J. K.
Vishwanatha, S. Shelake, L. Tabor-Simecka, M. Shoji, J. W. Simecka,
and B. El-Rayes. 2016. Small molecule tolfenamic acid and dietary
spice curcumin treatment enhances antiproliferative effect in pancre-
atic cancer cells via suppressing Sp1, disrupting NF-kB translocation
to nucleus and cell cycle phase distribution. The Journal of
Nutritional Biochemistry 31:77–87. doi: 10.1016/j.jnutbio.2016.01.003.
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